CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents

被引：9

作者：

Papageorgiou, Ioannis ^{[1
,2
]}

Loken, Michael R. ^{[3
]}

Brodersen, Lisa Eidenschink ^{[3
]}

Gbadamosi, Mohammed ^{[1
,2
]}

Uy, Geoffrey L. ^{[4
]}

Meshinchi, Soheil ^{[5
]}

Lamba, Jatinder K. ^{[1
,2
]}

机构：

[1] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA

[2] Univ Florida, Coll Pharm, Ctr Pharmacogenet, Gainesville, FL USA

[3] Hematologics Inc, Seattle, WA USA

[4] Washington Univ, Div Oncol, St Louis, MO 63110 USA

[5] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA USA

来源：

关键词：

GEMTUZUMAB-OZOGAMICIN; PEDIATRIC-PATIENTS; POLYMORPHISMS; CELLS;

D O I：

10.1080/10428194.2019.1569232

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2287 / 2290

页数：4